"Voted one of America's Top Docs and the Best Doctors in America, Dr. Schlessinger has also been consistently voted as the best Omaha dermatologist and cosmetic surgeon for more than 16 years. Dr. Joel Schlessinger has devoted his life to dermatology and skin health. As a board certified dermatologist and general cosmetic surgeon in Omaha, Nebraska, Dr. Schlessinger has more than 20 years of experience treating a wide variety of skin conditions. Dr. Schlessinger is also the founder of the Advanced Skin Research Center, a clinical research facility that investigates new medications and treatments for a wide range of skin conditions and cosmetic procedures."

During the past decade, Skin Specialists, PC conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 30 clinical trials were completed, i.e. on average, 93.8% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 19 clinical trials were completed. i.e. 135.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Skin Specialists, PC" #1 sponsor was "Pfizer" with 10 trials, followed by "Galderma R&D" with 7 trials sponsored, "Allergan" with 4 trials sponsored, "Peplin" with 4 trials sponsored and "Eli Lilly and Company" with 4 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Skin Specialists, PC" #1 collaborator was "GlaxoSmithKline" with 2 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "Symbio, LLC" with 2 trials as a collaborator, "Allergan" with 1 trials as a collaborator and "Athenex, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Skin Specialists, PC" are "Atopic Dermatitis" (10 trials), "Acne Vulgaris" (8 trials), "Psoriasis" (6 trials), "Actinic Keratosis" (4 trials) and "Actinic Keratoses" (3 trials). Many other conditions were trialed in "Skin Specialists, PC" in a lesser frequency.

Most popular intervention types in "Skin Specialists, PC" are "Drug" (55 trials), "Biological" (5 trials), "Other" (5 trials), "Device" (4 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Vehicle" (5 trials), "Abrocitinib 200 mg" (2 trials), "Baricitinib" (2 trials) and "CP-690,550" (2 trials). Other intervention names were less common.

The vast majority of trials in "Skin Specialists, PC" are 61 trials for "All" genders.

Currently, there are NaN active trials in "Skin Specialists, PC". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 50 completed trials in Skin Specialists, PC, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Skin Specialists, PC, 1 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 2 trials that are defined as “Not Applicable".